Survival outcomes and treatment costs for patients with double‐refractory chronic lymphocytic leukaemia (DR‐CLL)

E-ISSN： 1365-2141|169|3|449-452

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.169, Iss.3, 2015-05, pp. : 449-452

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ofatumumab retreatment and maintenance in fludarabine‐refractory chronic lymphocytic leukaemia patients

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 1, 2015-07 ,pp. : 40-49

John Wiley & Sons Inc

Access to resources Recommend Favorite

The clinical significance of hypogammaglobulinaemia and serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukaemia (CLL)

By Best Oliver G. Crassini Kyle Freeman Jane A. Mulligan Stephen P.

Scandinavian Journal of Infectious Diseases, Vol. 45, Iss. 9, 2013-09 ,pp. : 729-729

Informa Healthcare

Access to resources Recommend Favorite

The addition of CD20 monoclonal antibodies to lenalidomide improves response rates and survival in relapsed/refractory patients with chronic lymphocytic leukaemia relative to lenalidomide monotherapy – the MD Anderson Cancer Center experience

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 2, 2015-10 ,pp. : 281-284

John Wiley & Sons Inc

Access to resources Recommend Favorite

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 7-1048, Iss. 2, 2015-10 ,pp. : 281-284

John Wiley & Sons Inc

Access to resources Recommend Favorite

Optimising outcomes for patients with chronic lymphocytic leukaemia on ibrutinib therapy: European recommendations for clinical practice

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 5, 2018-03 ,pp. : 666-679

John Wiley & Sons Inc

Access to resources Recommend Favorite